Table 6. Subgroup analysis of each metabolic genotype.
| Items | Sum, n (%) | Good prognosis, n (%) | Poor prognosis, n (%) | χ2 | P |
|---|---|---|---|---|---|
| NM | 0.244 | 0.621 | |||
| Ticagrelor group | 26 (41.3) | 16 (61.5) | 10 (38.5) | ||
| Clopidogrel group | 37 (58.7) | 25 (67.6) | 12 (32.4) | ||
| IM | 9.697 | 0.002 | |||
| Ticagrelor group | 37 (56.9) | 25 (67.6) | 12 (32.4) | ||
| Clopidogrel group | 28 (43.1) | 8 (28.6) | 20 (71.4) | ||
| PM | 0.878 | 0.417 | |||
| Ticagrelor group | 9 (39.1) | 5 (55.6) | 4 (44.4) | ||
| Clopidogrel group | 14 (60.9) | 5 (35.7) | 9 (64.3) |
NM, normal metabolism; IM, intermediate metabolism; PM, poor metabolism.